An Enhanced Medication Monitoring Program
Status: | Completed |
---|---|
Conditions: | High Blood Pressure (Hypertension) |
Therapuetic Areas: | Cardiology / Vascular Diseases |
Healthy: | No |
Age Range: | 55 - Any |
Updated: | 4/2/2016 |
Start Date: | September 2011 |
End Date: | June 2013 |
Contact: | Sundar Natarajan, MD, M.Sc |
Email: | sundar.natarajan@va.gov |
Phone: | 212-951-3395 |
The goal of the Enhanced Medication Management Program (eMMp) being developed by MedMinder
Systems, Inc. is to increase the ability of frail elders to adhere to complex medication
regimens for chronic conditions. Adherence will facilitate effective self-care and decrease
personal and societal costs associated with disease progression and loss of independence.
Multiple studies have shown that more frequent personal follow-up is the most effective way
to maximize medication adherence, but such personal care is too costly to translate well to
real life in a world of limited healthcare resources.
Currently available "smart pillboxes" are too expensive, too limited in the number and types
of medications delivered, and too technically complex for the large majority of senior
citizens. The eMMp is designed to deliver prompts and reminders to the user, to be remotely
programmable by caregivers, to allow the option of using pre-filled medication trays, to
provide electronic adherence reports to family/caregivers and to provide personalized
reinforcing phone calls from professional caregivers, all at a modest cost. The in-home
ReMinder will use a familiar pillbox layout (4 doses/day for 7 days) and allow easy removal
of medication cups by elderly, rheumatic fingers. Installation will require only an
electrical outlet (no modems or dedicated phone lines). Once plugged in, the built-in pager
will continuously download remotely programmed visual and/or aural prompts and reminders
from a central server (RemoteMind). It will continuously upload the date and time when each
medi-cation cup is removed and when weekly refill is carried out, enabling remote adherence
monitoring, alerts to caregivers, and follow-up intervention(s) from personal and/or
professional caregivers as needed.
The hypothesis to be tested in this 2 year SBIR Phase I work plan is that the eMMp will
significantly im-prove adherence and clinical outcome (blood pressure control) in a
population of frail elderly who are hyper-tensive. SBIR Phase II will determine the minimum
level of intervention needed to achieve sustained medication adherence and control of blood
pressure in a larger group of hypertensive elders.
Systems, Inc. is to increase the ability of frail elders to adhere to complex medication
regimens for chronic conditions. Adherence will facilitate effective self-care and decrease
personal and societal costs associated with disease progression and loss of independence.
Multiple studies have shown that more frequent personal follow-up is the most effective way
to maximize medication adherence, but such personal care is too costly to translate well to
real life in a world of limited healthcare resources.
Currently available "smart pillboxes" are too expensive, too limited in the number and types
of medications delivered, and too technically complex for the large majority of senior
citizens. The eMMp is designed to deliver prompts and reminders to the user, to be remotely
programmable by caregivers, to allow the option of using pre-filled medication trays, to
provide electronic adherence reports to family/caregivers and to provide personalized
reinforcing phone calls from professional caregivers, all at a modest cost. The in-home
ReMinder will use a familiar pillbox layout (4 doses/day for 7 days) and allow easy removal
of medication cups by elderly, rheumatic fingers. Installation will require only an
electrical outlet (no modems or dedicated phone lines). Once plugged in, the built-in pager
will continuously download remotely programmed visual and/or aural prompts and reminders
from a central server (RemoteMind). It will continuously upload the date and time when each
medi-cation cup is removed and when weekly refill is carried out, enabling remote adherence
monitoring, alerts to caregivers, and follow-up intervention(s) from personal and/or
professional caregivers as needed.
The hypothesis to be tested in this 2 year SBIR Phase I work plan is that the eMMp will
significantly im-prove adherence and clinical outcome (blood pressure control) in a
population of frail elderly who are hyper-tensive. SBIR Phase II will determine the minimum
level of intervention needed to achieve sustained medication adherence and control of blood
pressure in a larger group of hypertensive elders.
Inclusion Criteria:
- persons aged 55 years and older who are coming in for routine outpatient visits
- speaks and reads English
- history of high blood pressure
- systolic blood pressure ≥ 130 mm Hg
- using antihypertensive medication
- using 2 or more prescription medications
- plans to stay in area for the 9 months of study
Exclusion criteria:
- receives personal help or reminders to take medication
- has moderate to severe dementia (MMSE score<18)
- has severe hearing or vision deficiency
We found this trial at
1
site
Click here to add this to my saved trials